Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%


According to a new market report published by Transparency Market Research "Insulin Market - Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018" the global insulin market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018, growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected to increase its share in the global insulin market to 10.2% by 2018.

The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin and not even being diagnosed. This however, presents a huge supply demand deficit for insulin, with high growth potential in developing markets. The factors contributing to the insulin market growth also includes increase in global expenditure on healthcare, strong distribution network, and high scope in developing economies such as China and India.

It is estimated that worldwide, by year 2030, one in ten people will suffer from diabetes, giving rise to huge demand for insulin. China, being the most populous nation in the world, accounts for the largest share of the global diabetic population and eventually turns out as the most lucrative market for insulin manufacturers.

The China insulin market is projected to grow at a CAGR twice that of the global insulin market. It was estimated at USD 723.8 million in 2011, and is projected to reach USD 3,299.1 million in the year 2018, growing at a CAGR of 24.6%. Currently, China accounts for 6.1% of the global insulin market in terms of volume, which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected to grow at a CAGR of 7.9% from 2012 - 2018.

The global insulin market has continuously witnessed new advanced product types being introduced in the market by insulin manufacturers. The recent product type is modern insulin, which is a genetically engineered version of human insulin, and has been selectively modified to counter the issues associated with human insulin. Currently, modern insulin accounts for more than 76% of the global insulin market.

To meet the rising demand, global insulin manufacturers are not only augmenting existing production facilities, but also expanding their global presence to meet the supply demand gap. Leading insulin manufacturers are now focusing on reinforcing their market leadership in China. It includes key global and China insulin market players such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for more than 90% of the global insulin market share.

This research is specially designed to estimate and analyze the demand and performance of the global and China insulin market in the current market scenario. This research provides in-depth analysis of insulin manufacturers, product sales, trend analysis by segments, and demand by geography. 

The report covers all the major product segments of the global and China insulin market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global and China insulin market as below:

By Action
  • Short Acting
  • Pre-mixes
  • Long Acting
By Type
  • Modern
  • Human
  • Animal

By Purchase Type
  • Dosage
  • Bulk

» Read More...

Skincare Devices Market (2012 - 2018)


Skincare devices are gaining importance not only due to their extensive use in aesthetics but also the increasing incidence of skin disorders worldwide. This report studies the market for skincare devices from two aspects, the different product types and applications. Each of these segments has been further divided into sub-segments; the products segment has been categorized into diagnostic and treatment devices.

Diagnostic devices include dermatoscopes, biopsy devices and image guidance systems whereas treatment devices comprise of lasabrasion devices, microdermabrasion devices, liposuction devices, electrosurgical devices, cryotherapy devices and LED therapy devices. Market size and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments, in terms of USD million, considering 2011 as the base year. The % CAGR for each market segment for the forecast period has been provided along with market size estimations.

The market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section features a detailed analysis of factors such as drivers, restraints and opportunities that affect the market dynamics, along with market attractiveness analysis and Porter’s five force analysis for the skincare devices market.

The competitive landscape section includes market share analysis of all the leading players in this market, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Alma Lasers Ltd., Cynosure, Inc., Cutera, Inc., PhotoMedex, Inc., Solta Medical Ltd. and Syneron Medical.

The global skincare devices market is segmented into the following categories:

Skincare Devices Market, by Product
  • Diagnostic devices, by type
    • Dermatoscopes
    • Biopsy devices
    • Image guidance systems
  • Treatment devices, by type
    • Lasabrasion devices
    • Microdermabrasion devices
    • Electrosurgical devices
    • Liposuction devices
    • Cryotherapy devices
    • LED therapy devices
Skincare Devices Market, by Application
  • Disease diagnosis & treatment
  • Skin rejuvenation
  • Hair removal
  • Cellulite reduction
  • Skin tightening & body contouring
  • Damage repair
Skincare Devices Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

» Read More...

Search This Blog

About Me

My photo

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.

Archives

Business Research Industry. Powered by Blogger.